• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量茶碱联合倍氯米松对哮喘吸烟者肺功能的影响:一项初步研究。

Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study.

作者信息

Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, Lafferty J, Chaudhuri R, Braganza G, Adcock I M, Barnes P J, Wood S, Thomson N C

机构信息

Faculty of Medicine, University of Glasgow, Glasgow, UK.

出版信息

Eur Respir J. 2009 May;33(5):1010-7. doi: 10.1183/09031936.00158208. Epub 2009 Feb 5.

DOI:10.1183/09031936.00158208
PMID:19196814
Abstract

Smoking is common in asthma and is associated with worse asthma control and a reduced therapeutic response to corticosteroids. The present authors hypothesised that treating smokers with asthma with low-dose theophylline added to inhaled corticosteroids would enhance steroid sensitivity and thereby improve lung function and symptoms. In a double-blind, parallel group exploratory trial, 68 asthmatic smokers were randomised to one of three treatments for 4 weeks: inhaled beclometasone (200 microg day(-1)), theophylline (400 mg day(-1)) or both treatments combined. Outcome measures included change in lung function and Asthma Control Questionnaire (ACQ) scores. At 4 weeks, theophylline added to inhaled beclometasone produced an improvement in peak expiratory flow (39.9 L min(-1), 95% confidence intervals (CI) 10.9-68.8) and ACQ score (-0.47, 95% CI -0.91- -0.04) and a borderline improvement in pre-bronchodilator forced expiratory volume in one second (mean difference 165 mL, 95% CI -13-342) relative to inhaled corticosteroid alone. Theophylline alone improved the ACQ score (-0.55, 95% CI -0.99- -0.11), but not lung function. In the present pilot study, the combination of low-dose theophylline and inhaled beclometasone produced improvements in both lung function and symptoms in a group of smokers with asthma. Larger trials are required to extend and confirm these findings.

摘要

吸烟在哮喘患者中很常见,并且与哮喘控制不佳以及对皮质类固醇的治疗反应降低有关。本文作者推测,对于患有哮喘的吸烟者,在吸入皮质类固醇的基础上加用低剂量氨茶碱进行治疗,会增强类固醇敏感性,从而改善肺功能和症状。在一项双盲、平行组探索性试验中,68名哮喘吸烟者被随机分为三种治疗方案之一,为期4周:吸入倍氯米松(200微克/天)、氨茶碱(400毫克/天)或两种治疗联合使用。观察指标包括肺功能变化和哮喘控制问卷(ACQ)评分。4周时,在吸入倍氯米松基础上加用氨茶碱,相对于单独使用吸入皮质类固醇,呼气峰值流速有所改善(39.9升/分钟,95%置信区间(CI)10.9 - 68.8),ACQ评分有所改善(-0.47,95%CI -0.91 - -0.04),支气管扩张剂使用前一秒用力呼气量有临界改善(平均差值165毫升,95%CI -13 - 342)。单独使用氨茶碱可改善ACQ评分(-0.55,95%CI -0.99 - -0.11),但对肺功能无改善。在本初步研究中,低剂量氨茶碱与吸入倍氯米松联合使用,使一组哮喘吸烟者的肺功能和症状均得到改善。需要进行更大规模的试验来扩展和证实这些发现。

相似文献

1
Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study.低剂量茶碱联合倍氯米松对哮喘吸烟者肺功能的影响:一项初步研究。
Eur Respir J. 2009 May;33(5):1010-7. doi: 10.1183/09031936.00158208. Epub 2009 Feb 5.
2
Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma.在哮喘治疗中,将茶碱添加到吸入性类固醇与将吸入性类固醇剂量加倍的比较。
Eur Respir J. 1997 Dec;10(12):2754-60. doi: 10.1183/09031936.97.10122754.
3
Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.在持续性哮喘患者中,将白三烯受体拮抗剂或低剂量茶碱添加至低或中剂量吸入性糖皮质激素的效果。
Chest. 2002 Jul;122(1):151-9. doi: 10.1378/chest.122.1.151.
4
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.吸入性糖皮质激素联合茶碱与双倍剂量吸入性糖皮质激素治疗中重度哮喘的比较
Respirology. 2005 Mar;10(2):189-95. doi: 10.1111/j.1440-1843.2005.00697.x.
5
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.在哮喘患者中,采用布地奈德-福莫特罗作为维持和缓解治疗药物:一项双盲、随机对照试验。
Lancet Respir Med. 2013 Mar;1(1):23-31. doi: 10.1016/S2213-2600(13)70012-2. Epub 2013 Mar 4.
6
Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma.倍氯米松、色甘酸和茶碱治疗对支气管哮喘患者支气管收缩感知的影响。
Clin Sci (Lond). 1996 Mar;90(3):227-34. doi: 10.1042/cs0900227.
7
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.低剂量吸入布地奈德联合茶碱与高剂量吸入布地奈德治疗中度哮喘的比较。
N Engl J Med. 1997 Nov 13;337(20):1412-8. doi: 10.1056/NEJM199711133372002.
8
Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.沙美特罗加吸入性糖皮质激素治疗优于加倍吸入性糖皮质激素剂量:一项随机临床试验。
J Asthma. 1999 Dec;36(8):703-15. doi: 10.3109/02770909909055422.
9
Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial.短期阿托伐他汀治疗对哮喘吸烟者的影响——一项随机对照试验。
BMC Pulm Med. 2011 Apr 7;11:16. doi: 10.1186/1471-2466-11-16.
10
Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years.轻度哮喘患者被随机分配接受吸入性糖皮质激素治疗或非糖皮质激素治疗两年后的骨矿物质密度。
Thorax. 2001 Apr;56(4):272-8. doi: 10.1136/thorax.56.4.272.

引用本文的文献

1
Advancing Obstructive Airway Disease Treatment: Dual PDE3/4 Inhibition as a Therapeutic Strategy.推进阻塞性气道疾病治疗:双重磷酸二酯酶3/4抑制作为一种治疗策略。
Cells. 2025 Apr 30;14(9):659. doi: 10.3390/cells14090659.
2
Effects of theophylline combined with inhaled corticosteroids on patients with moderate and severe asthma and changes of T lymphocyte subsets in peripheral blood.茶碱联合吸入性糖皮质激素对中重度哮喘患者的疗效及外周血T淋巴细胞亚群的变化
Cent Eur J Immunol. 2023;48(2):135-143. doi: 10.5114/ceji.2023.127843. Epub 2023 Jun 30.
3
Occupational Asthma Prevalence among Migrant Workers Attending Shuaiba Industrial Medical Center in Kuwait.
科威特舒艾拜工业医疗中心就诊的外来务工人员中的职业性哮喘患病率
Healthcare (Basel). 2023 Jul 13;11(14):2021. doi: 10.3390/healthcare11142021.
4
Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD.蛋白质组学和代谢组学分析揭示了稳定期 COPD 患者循环诊断生物标志物和分子亚型的特征。
Respir Res. 2023 Mar 11;24(1):73. doi: 10.1186/s12931-023-02349-x.
5
Asthma and Tobacco Smoking.哮喘与吸烟
J Pers Med. 2022 Jul 27;12(8):1231. doi: 10.3390/jpm12081231.
6
Possible Treatment Approaches of Sulfur Mustard-Induced Lung Disorders, Experimental and Clinical Evidence, an Updated Review.硫芥诱导的肺部疾病的可能治疗方法:实验与临床证据,最新综述
Front Med (Lausanne). 2022 Apr 29;9:791914. doi: 10.3389/fmed.2022.791914. eCollection 2022.
7
Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma.海洋来源化合物在治疗严重哮喘糖皮质激素抵抗中的潜在应用。
Mar Drugs. 2021 Oct 20;19(11):586. doi: 10.3390/md19110586.
8
Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD.氧化应激促进哮喘和慢性阻塞性肺疾病中的皮质类固醇不敏感性。
Antioxidants (Basel). 2021 Aug 24;10(9):1335. doi: 10.3390/antiox10091335.
9
Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract.以粘蛋白改善倍氯米松在脂质体和透明质体中的负载,作为对抗香烟烟雾提取物产生的氧化应激的有效方法。
Nanomaterials (Basel). 2021 Mar 26;11(4):850. doi: 10.3390/nano11040850.
10
Why do some asthma patients respond poorly to glucocorticoid therapy?为什么有些哮喘患者对糖皮质激素治疗反应不佳?
Pharmacol Res. 2020 Oct;160:105189. doi: 10.1016/j.phrs.2020.105189. Epub 2020 Sep 8.